Vascular Inflammation Imaging with 18F-FDG PET/CT for In-Stent Restenosis after Intracranial Stent Deployment in a Swine Model (S51.002)

Zhong‐Song Shi,Zhong Liu,Jinshan Wang,Donghong Liu,Xiulin Shi,Xiangsong Zhang,Deji Chen,Ying Liu,Yanqiu Li,Hongtao Wang,Lei Feng
DOI: https://doi.org/10.1212/wnl.82.10_supplement.s51.002
IF: 9.9
2014-01-01
Neurology
Abstract:Objective: To evaluate the association of in-stent restenosis after intracranial stent implantation with vascular inflammation identified by increased FDG uptake on PET/CT in a swine atherosclerotic model. Background: In-stent restenosis occurs frequently after stenting of symptomatic intracranial atherosclerotic stenosis. 18F-FDG PET can detect inflammation in the atherosclerotic plaque. Design/Methods: Advanced atherosclerotic plaques were induced in 28 carotid arteries of 14 Chinese miniswines using partial ligation and high cholesterol diet to create >70% stenosis. The plaques were characterized with three-dimensional rotational angiography, Doppler ultrasonography, and MR scan at three months and correlated with histopathological examination in 20 carotid arteries. Serial 18F-FDG PET/CT scans were performed at 0, 1, 2 and 3 months. Five Wingspan stents and one Paclitaxel-eluting balloon-mounted coronary stent were implanted into six diseased vessels. Dual-antiplatelet regimen with clopidogrel and aspirin was administrated 1 day prior to stenting and continued for 1 month. Stent and plaque interaction was evaluated with angiography, MR scan and PET/CT scans at one month after stenting. Results: The diameter of proximal and distal segments of carotid arteries were 3.6 mm and 3.7 mm at 3 months, similar to that of MCA in human (2.7-4.9 mm, average 3.7mm). Doppler waveforms showed features of low resistant vessels. Plaque rupture and distal embolism were observed, mimicking the mechanisms of stroke in human intracranial atherosclerosis. FDG uptake increased continuously in both groups of advanced plaque and early atherosclerosis and was significantly higher in advanced plaques than in early atherosclerosis at 1, 2 and 3 months (P<0.01). All stents were patent at one month but 25% restenosis was observed. Nearly 50% increased FDG uptake was found at the sites of stented carotid segments, indicating progressive inflammation after intracranial stent deployment. Conclusions: This swine model is suitable for the testing of devices for the endovascular treatment of intracranial atherosclerosis. It can be a useful tool for the study of inflammation mechanisms of in-stent restenosis after intracranial stenting therapies. Disclosure: Dr. Shi has nothing to disclose. Dr. Liu has nothing to disclose. Dr. Wang has nothing to disclose. Dr. Liu has nothing to disclose. Dr. Shi has nothing to disclose. Dr. Zhang has nothing to disclose. Dr. Chen has nothing to disclose. Dr. Liu has nothing to disclose. Dr. Liu has nothing to disclose. Dr. Wang has nothing to disclose. Dr. Feng has nothing to disclose.
What problem does this paper attempt to address?